Medicare Enrolled
Dr. Jonathan Greer, M.D.
Rheumatology · Boynton Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Greer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Greer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Greer
Dr. Jonathan Greer is a rheumatology specialist in Boynton Beach, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Greer performed 193,314 Medicare services across 2,516 unique beneficiaries.
Between the years covered by Open Payments, Dr. Greer received a total of $847,246 from 54 pharmaceutical and/or device companies across 2594 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Greer is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in FL
$847,246 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 45242 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗193,314
Medicare services
Top 10% in FL for rheumatology
2,516
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,666 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 49,980 | $8 | $13 |
| Tocilizumab injection (Actemra) | 47,432 | $5 | $9 |
| Denosumab injection (Prolia/Xgeva) | 27,782 | $18 | $28 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
27,600 | $4 | $14 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
19,950 | $11 | $35 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
10,400 | $34 | $62 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
2,351 | $63 | $110 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
2,031 | $26 | $57 |
| Hymovis intra-articular injection An injection of Hymovis, a hyaluronan derivative, administered directly into a joint space. |
1,536 | $13 | $36 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,497 | $97 | $155 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
863 | $59 | $95 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
441 | $106 | $200 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
417 | $5 | $10 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
187 | $45 | $109 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
106 | $23 | $85 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
101 | $117 | $210 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
90 | $6 | $20 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
57 | $30 | $60 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
53 | $13 | $45 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
52 | $10 | $152 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
51 | $39 | $84 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
51 | $27 | $68 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
45 | $24 | $65 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
38 | $26 | $67 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
34 | $32 | $83 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
34 | $4 | $10 |
| Pelvis X-ray, 1-2 views An X-ray imaging test of the pelvic area using one to two different angles to visualize the bones and joints. |
32 | $19 | $58 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $62 | $110 |
| X-ray of middle spine, 2 views An X-ray imaging test that produces two views of the middle section of the spine to visualize the bones and joints. |
20 | $22 | $68 |
| X-ray of upper spine, 4-5 views An X-ray imaging test of the upper spine using 4 to 5 different views to visualize the bones and structures in that area. |
18 | $38 | $90 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
18 | $51 | $100 |
| Tendon injection at attachment site A procedure involving the injection of medication into a tendon where it attaches to bone or muscle. |
16 | $44 | $89 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.0% high complexity
82.0% medium
1.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$847,246
Total received (2018-2024)
Avg $121,035/year across 7 years
Top 1% in FL for rheumatology
54
Companies
2,594
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$735,181 (86.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$101,747 (12.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,319 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$109,031
2023
$103,615
2022
$116,135
2021
$66,207
2020
$68,384
2019
$201,720
2018
$182,155
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$253,310
Janssen Scientific Affairs, LLC
$139,144
UCB, Inc.
$107,064
Radius Health, Inc.
$88,688
Janssen Biotech, Inc.
$61,950
ABBVIE INC.
$55,536
Novartis Pharmaceuticals Corporation
$51,167
Lilly USA, LLC
$36,334
Horizon Therapeutics plc
$15,417
PFIZER INC.
$9,313
Gilead Sciences, Inc.
$5,364
Celgene Corporation
$4,025
OraPharma, a division of Bausch Health US, LLC
$3,970
AbbVie Inc.
$3,604
Cardinal Health 108, LLC
$2,568
GENZYME CORPORATION
$1,920
GlaxoSmithKline, LLC.
$1,454
Regeneron Healthcare Solutions, Inc.
$958
AbbVie, Inc.
$889
E.R. Squibb & Sons, L.L.C.
$879
Genentech USA, Inc.
$720
AstraZeneca Pharmaceuticals LP
$474
Actelion Pharmaceuticals US, Inc.
$264
Sobi, Inc
$202
Mallinckrodt Hospital Products Inc.
$199
ANI Pharmaceuticals, Inc.
$188
Mallinckrodt LLC
$183
Johnson & Johnson Health Care Systems Inc.
$134
Aurinia Pharma U.S., Inc.
$131
Genentech, Inc.
$110
Boehringer Ingelheim Pharmaceuticals, Inc.
$103
Fresenius Kabi USA, LLC
$101
Horizon Pharma plc
$92
SANOFI-AVENTIS U.S. LLC
$92
Alexion Pharmaceuticals, Inc.
$83
SOBI, INC
$80
Ferring Pharmaceuticals Inc.
$78
Alvogen Inc
$52
Organon LLC
$51
Kiniksa Pharmaceuticals, Ltd.
$42
Smith+Nephew, Inc.
$40
Kiniksa Pharmaceuticals International, plc
$35
Kowa Pharmaceuticals America, Inc.
$33
Allergan, Inc.
$28
FIDIA PHARMA USA INC.
$27
Fidia Pharma USA Inc.
$23
Kyowa Kirin, Inc.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$20
Novo Nordisk Inc
$16
Antares Pharma, Inc.
$15
Hikma Pharmaceuticals USA
$14
Flexion Therapeutics, Inc.
$13
MEDEXUS PHARMA, INC.
$12
Purdue Pharma L.P.
$12
Top 3 companies account for 59.0% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · Cimzia · Crysvita · DUEXIS · EUFLEXXA · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · HYMOVIS · HYQVIA · Humira · Hymovis · IDACIO · ILARIS · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KISUNLA · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · NEUTRASAL · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REAL INTELLIGENCE · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYMPROIC · SYNVISC-ONE · Seglentis · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tremfya · Tymlos · UBRELVY · Wegovy · XELJANZ · XYOSTED · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for rheumatology in FL.
Equivalent to $438 per 100 Medicare services performed
Geographic Context
Rheumatologists within 10 mi
63
Per 100K population
4.2
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
3.9 mi
3.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Greer is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), with speaking/promotional industry engagement in the top 1% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Greer experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Greer performed 49,980 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Greer receive payments from pharmaceutical companies?
Yes. Dr. Greer received a total of $847,246 from 54 companies across 2,594 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Greer's costs compare to other rheumatologists in Boynton Beach?
Dr. Greer's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Greer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Boynton Beach
Browse rheumatologists in Boynton Beach ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology